Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1979-01-24
1980-10-14
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
536103, A61K 3170, C08B 3716
Patent
active
042281601
ABSTRACT:
The invention relates to an inclusion complex of 1-(p-chloro-benzoyl)-5-methoxy-2-methyl-indol-3-yl-acetic acid (indomethacin) and cyclodextrin of a molar ratio of about 2:1. The inclusion complex can be prepared by reacting about 2 moles of alpha or beta cyclodextrin with about 1 mole of 1-(p-chloro-benzoyl)-5-methoxy-2-methyl-indol-3-yl-acetic acid under heating in the presence of an organic solvent which dissolves indomethacin and does not form a stable complex with cyclodextrin. The new complex is at least as active antiinflammatory agent as indomethacin and at the same time shows substantially less ulcerative side-effect.
REFERENCES:
patent: 2959580 (1960-11-01), Schlenk et al.
patent: 3061444 (1962-10-01), Rogers et al.
patent: 4054736 (1977-10-01), Hayashi et al.
Frank, Sylvan G., Journal of Pharmaceutical Sciences, Oct. 1975, p. 1585.
Agr. Biol. Chem., vol. 34, No. 12, pp. 1787-1794 (1970).
Hamada et al., Chem. Pharm. Bull., 23, 1205 (1975).
Kurozumi et al., Chem. Pharm. Bull., 23, 3062 (1975).
David Agoston
Mandi Attila
Sebestyen Gyula
Szejtli Josef
Szente Lajos
Chinoin Gyogyszer - es Vegyeszeti Termekek Gyara Rt.
Friedman Stanley J.
Ross Karl F.
LandOfFree
Inclusion complex of cyclodextrin and indomethacin and a process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inclusion complex of cyclodextrin and indomethacin and a process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inclusion complex of cyclodextrin and indomethacin and a process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2101036